Literature DB >> 18154498

Addiction and the brain antireward system.

George F Koob1, Michel Le Moal.   

Abstract

A neurobiological model of the brain emotional systems has been proposed to explain the persistent changes in motivation that are associated with vulnerability to relapse in addiction, and this model may generalize to other psychopathology associated with dysregulated motivational systems. In this framework, addiction is conceptualized as a cycle of decreased function of brain reward systems and recruitment of antireward systems that progressively worsen, resulting in the compulsive use of drugs. Counteradaptive processes, such as opponent process, that are part of the normal homeostatic limitation of reward function fail to return within the normal homeostatic range and are hypothesized to repeatedly drive the allostatic state. Excessive drug taking thus results in not only the short-term amelioration of the reward deficit but also suppression of the antireward system. However, in the long term, there is worsening of the underlying neurochemical dysregulations that ultimately form an allostatic state (decreased dopamine and opioid peptide function, increased corticotropin-releasing factor activity). This allostatic state is hypothesized to be reflected in a chronic deviation of reward set point that is fueled not only by dysregulation of reward circuits per se but also by recruitment of brain and hormonal stress responses. Vulnerability to addiction may involve genetic comorbidity and developmental factors at the molecular, cellular, or neurocircuitry levels that sensitize the brain antireward systems.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18154498     DOI: 10.1146/annurev.psych.59.103006.093548

Source DB:  PubMed          Journal:  Annu Rev Psychol        ISSN: 0066-4308            Impact factor:   24.137


  514 in total

1.  Blunted vagal reactivity predicts stress-precipitated tobacco smoking.

Authors:  Rebecca L Ashare; Rajita Sinha; Rachel Lampert; Andrea H Weinberger; George M Anderson; Meaghan E Lavery; Katherine Yanagisawa; Sherry A McKee
Journal:  Psychopharmacology (Berl)       Date:  2011-09-21       Impact factor: 4.530

Review 2.  Cognitive neuroscience of self-regulation failure.

Authors:  Todd F Heatherton; Dylan D Wagner
Journal:  Trends Cogn Sci       Date:  2011-01-26       Impact factor: 20.229

3.  Alcohol stress response dampening: selective reduction of anxiety in the face of uncertain threat.

Authors:  Kathryn R Hefner; John J Curtin
Journal:  J Psychopharmacol       Date:  2011-09-21       Impact factor: 4.153

Review 4.  Function and dysfunction of prefrontal brain circuitry in alcoholic Korsakoff's syndrome.

Authors:  Marlene Oscar-Berman
Journal:  Neuropsychol Rev       Date:  2012-04-27       Impact factor: 7.444

5.  Social dominance in female monkeys: dopamine receptor function and cocaine reinforcement.

Authors:  Michael A Nader; Susan H Nader; Paul W Czoty; Natallia V Riddick; H Donald Gage; Robert W Gould; Brandi L Blaylock; Jay R Kaplan; Pradeep K Garg; Huw M L Davies; Daniel Morton; Sudha Garg; Beth A Reboussin
Journal:  Biol Psychiatry       Date:  2012-04-14       Impact factor: 13.382

6.  Where is the pleasure in that? Low hedonic capacity predicts smoking onset and escalation.

Authors:  Janet Audrain-McGovern; Daniel Rodriguez; Adam M Leventhal; Jocelyn Cuevas; Kelli Rodgers; Joseph Sass
Journal:  Nicotine Tob Res       Date:  2012-03-01       Impact factor: 4.244

7.  The Neurobiology of Addiction: Where We Have Been and Where We Are Going.

Authors:  George F Koob; Eric J Simon
Journal:  J Drug Issues       Date:  2009-01

8.  Greater elevation in risk for nicotine dependence per pack of cigarettes smoked among those with an anxiety disorder.

Authors:  Matt G Kushner; Kyle R Menary; Eric W Maurer; Paul Thuras
Journal:  J Stud Alcohol Drugs       Date:  2012-11       Impact factor: 2.582

9.  Elevated glucocorticoid levels are responsible for induction of tyrosine hydroxylase mRNA expression, phosphorylation, and enzyme activity in the nucleus of the solitary tract during morphine withdrawal.

Authors:  Cristina Núñez; Anna Földes; Domingo Pérez-Flores; J Carlos García-Borrón; M Luisa Laorden; Krisztina J Kovács; M Victoria Milanés
Journal:  Endocrinology       Date:  2009-01-29       Impact factor: 4.736

10.  Chromatin remodeling: a new landscape to treat harmful alcohol-use disorders.

Authors:  Vincent Warnault; Dorit Ron
Journal:  Future Med Chem       Date:  2013-11       Impact factor: 3.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.